AGC
TEVA icon

Angelo Gordon & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Angelo Gordon & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-86,600
Closed -$4.66M – 75
2014
Q3 		$4.66M Hold
86,600
– – 0.31% 53
2014
Q2 		$4.54M Buy
+86,600
New +$4.43M 0.36% 49

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Angelo Gordon & Co's TEVA Position: Q4 2014 in Review

Angelo Gordon & Co sold out of Teva Pharmaceuticals (TEVA) in Q4 2014, closing a stake of 86,600 shares — an estimated $4.66M sold.

Angelo Gordon & Co first reported a position in TEVA in Q2 2014 and held it in 2 quarters. The position peaked at $4.66M in Q3 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

  • Angelo Gordon & Co reported no remaining Teva Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Angelo Gordon & Co sold 86,600 Teva Pharmaceuticals shares in Q4 2014, an estimated $4.66M.
  • Angelo Gordon & Co first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Angelo Gordon & Co's Teva Pharmaceuticals position peaked at $4.66M in Q3 2014.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Angelo Gordon & Co's 13F filing for Q4 2014, filed 13 Feb 2015.